⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockBelgiumNasdaqGS

LKFT

Lakefront Biotherapeutics NV

Healthcare · Biotechnology

32.28USD

-0.0500 (-0.15%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on LKFT.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(EUR)
1)

Issue Data

Last PxUSD / 32.28
P/E3.6
Dvd Ind Yld0.0%
P/B0.65
P/S2.1
Curr EV/T12M EBITDA—
Mkt Cap (USD)2.1B
Curr EV (USD)—
2)

Per Share Data

EPS T12M4.87
DPS—
Bk Val Per Sh2.79
Rev/Sh15.04
Cash/Sh1.71
Curr Shares Out65.9M
FCF/Sh-3.51
3)

Cash Flow Analysis

P/CF-9.4
Curr P/FCF-9.2
CF/NI-0.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-22.9%
Eff Interest Rate34.8%
4)

Growth Potential

Dil EPS 1Y Gr334.8%
Cap 1Y Gr11.7%
BPS 1Y Gr12.1%
R&D To Sales24.0%
Retention Rate100.0%
Rev 1Y Gr303.5%
FCF 1Y Gr32.5%
Assets 1Y Gr-17.6%
5)

Profitability

EBITDA0.6B
EBIT0.6B
Operating Margin61.6%
Pretax Margin58.3%
Net Margin60.2%
ROA16.6%
ROE20.2%
ROC—
Asset Turnover0.28
6)

Structure

Current Ratio32.84
Quick Ratio32.65
Debt/Assets0.2%
Debt/Com Eq0.2%
Net Debt/EBITDA-0.23
Tot Debt/Capital0.2%
Gross Margin97.5%
EBIT/Int Exp275.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years. This company reports in a different currency from the one its shares trade in, so any ratio dividing a market value by a statement figure crosses that boundary un-converted.